Novo Nordisk: Be Greedy When Others Are Fearful
Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...
Armed robbery in Revesby1h
GLP-1, SGLT2 Drugs Cut Heart Risk for Stroke Survivors
In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 ...
Armed robbery in Revesby3h
GLP-1, SGLT2 Drugs Cut Stroke Survivors' Heart Risk
In an analysis of more than 7,000 stroke survivors, those who were taking either a GLP1-receptor agonist or an SGLT2 inhibitor ...
New Atlas20h
Weight-loss pill passes important safety test in clinical trial
In good news for those averse to injections, GLP-1 agonist medication is a step closer to being offered in oral pill form, ...